Business Context and Reporting Period
Company: National Health Investors Inc. (NHI)
Filing Type: Form 8-K (Current Report)
Date of Report: August 14, 2024
Reporting Period: The filing covers the entry into a material underwriting agreement and forward sale agreements dated August 14, 2024, with the offering closing on August 16, 2024.
Key Financial Metrics and Transaction Details
- Transaction Type: Forward sale of common stock.
- Shares Offered: 2,760,000 shares of Common Stock (including 360,000 shares from the full exercise of the underwriters' option).
- Price Per Share: $68.40 (initial forward sale price, representing the public offering price less underwriting discount).
- Estimated Net Proceeds: Approximately $188.3 million, assuming full physical settlement and after estimated offering expenses.
- Settlement Terms: Expected physical settlement within approximately twelve months; cash or net share settlement options exist but would result in no proceeds to the company.
- Underwriters: BofA Securities, Inc., J.P. Morgan Securities LLC, Wells Fargo Securities, LLC, and BMO Capital Markets Corp.
Material Changes and Use of Proceeds
This filing represents a material change in the company's capital structure and liquidity position pending settlement. The company intends to use the net proceeds for:
- Working capital and general corporate purposes.
- Funding acquisitions of additional properties or businesses.
- Repayment of short-term and long-term debt.
- Investments in mortgages.
Note: The actual cash received depends on the settlement method, market interest rates, and the prevailing market price of the Common Stock during the settlement period.
Guidance, Risks, and Contingencies
- Settlement Risk: The company may not receive any proceeds if it elects cash settlement or net share settlement under the Forward Sale Agreements.
- Market Risk: Proceeds are subject to price adjustments based on market conditions over the next twelve months.
- Acceleration: Settlement may be accelerated by the Forward Purchasers upon the occurrence of certain events.
- Liabilities: The company has agreed to indemnify the underwriters and forward sellers against certain liabilities.
Investor Verification Checklist
- Verify the final settlement method (physical, cash, or net share) to confirm actual proceeds received.
- Monitor the prevailing market price of NHI stock over the next 12 months to assess potential price adjustments to the $68.40 forward price.
- Review the full text of the Underwriting Agreement (Exhibit 1.1) and Forward Sale Agreements (Exhibits 1.2–1.5) for specific acceleration triggers and adjustment formulas.
- Confirm the allocation of proceeds between debt repayment and new acquisitions in future filings.